kabutan

Nxera Pharma, Last Fiscal Year's Net Income Loss Narrows, Current period performance is undisclosed.

Fri Feb 14, 2025 3:30 pm JST Earnings

4565 Nxera Pharma Co., Ltd. 【IFRS】

Earnings Report

Nxera Pharma Co., Ltd. <4565> [TSE Prime] announced its financial results (based on IFRS) after the market closed on February 14th (15:30). The consolidated net loss for the fiscal year ending December 2024 was loss of 4.83 billion yen, a reduction in the deficit compared to loss of 4.83 billion yen in the previous term. Furthermore, the company did not disclose the performance outlook for the fiscal year ending December 2025.

In the most recent three-month period, from October to December (4Q), the consolidated net loss expanded to a loss of 1.33 billion yen (compared to a loss of 0.2 billion yen in the same period last year). The operating profit/loss margin drastically worsened from -21.0% in the same period last year to -37.6%.

Kabutan News

Actual Results

Historical Performance
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2022 15,569 3,436 1,078 382 4.7 0 Feb 14, 2023 IFRS
Dec, 2023 12,766 -9,526 -10,680 -7,193 -87.2 0 Feb 13, 2024 IFRS
Dec, 2024 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
YoY +125.9% +43.1% +56.3% +32.7% +38.2%

Full Year Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2024 Guidance ー ー ー ー － 0 Feb 13, 2024 IFRS
Dec, 2024 Results 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
Revision Rate － － － － －

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jan - Jun, 2024 12,720 -3,654 -3,158 -4,703 -52.5 0 Aug 9, 2024 IFRS
Jan - Jun, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2023 12,766 -9,526 -10,680 -7,193 -87.2 0 Feb 13, 2024 IFRS
Dec, 2024 28,835 -5,423 -4,662 -4,838 -53.9 0 Feb 14, 2025 IFRS
Dec, 2025 Guidance ー ー ー ー － 0 Feb 14, 2025 IFRS
YoY － － － － －

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2023 7,292 -1,534 -2,815 -208 -2.5 -21.0 Feb 13, 2024 IFRS
Jan - Mar, 2024 4,611 -3,076 -2,796 -3,281 -36.7 -66.7 May 9, 2024 IFRS
Apr - Jun, 2024 8,109 -578 -362 -1,422 -15.9 -7.1 Aug 9, 2024 IFRS
Jul - Sep, 2024 9,263 808 865 1,200 13.4 8.7 Nov 1, 2024 IFRS
Oct - Dec, 2024 6,852 -2,577 -2,369 -1,335 -14.9 -37.6 Feb 14, 2025 IFRS
YoY -6.0% -68.0% +15.8% -541.8% -490.5%

Related Articles